These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 25063874)
1. Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2. Ji Z; Fan Z; Zhang Y; Yu R; Yang H; Zhou C; Luo J; Ke ZJ J Immunol; 2014 Sep; 193(5):2157-67. PubMed ID: 25063874 [TBL] [Abstract][Full Text] [Related]
2. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage. Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191 [TBL] [Abstract][Full Text] [Related]
3. Comment on "Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2". Fang B; Lennon VA J Immunol; 2014 Nov; 193(10):4755. PubMed ID: 25381354 [No Abstract] [Full Text] [Related]
4. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934 [TBL] [Abstract][Full Text] [Related]
5. Response to Comment on "Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2". Ke ZJ; Luo J J Immunol; 2014 Nov; 193(10):4755-6. PubMed ID: 25381355 [No Abstract] [Full Text] [Related]
6. Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology. Batoulis H; Recks MS; Holland FO; Thomalla F; Williams RO; Kuerten S Clin Exp Immunol; 2014 Jan; 175(1):41-8. PubMed ID: 24111507 [TBL] [Abstract][Full Text] [Related]
7. Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses. Lee MJ; Jang M; Choi J; Lee G; Min HJ; Chung WS; Kim JI; Jee Y; Chae Y; Kim SH; Lee SJ; Cho IH Mol Neurobiol; 2016 Apr; 53(3):1419-1445. PubMed ID: 25579380 [TBL] [Abstract][Full Text] [Related]
8. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System. Samus M; Li YT; Sorokin L; Rottner K; Vestweber D J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458 [TBL] [Abstract][Full Text] [Related]
9. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System. Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B Front Immunol; 2019; 10():2436. PubMed ID: 31681316 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis. Chen SJ; Wang YL; Lo WT; Wu CC; Hsieh CW; Huang CF; Lan YH; Wang CC; Chang DM; Sytwu HK Clin Exp Immunol; 2010 Nov; 162(2):210-23. PubMed ID: 21069936 [TBL] [Abstract][Full Text] [Related]
11. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535 [TBL] [Abstract][Full Text] [Related]
12. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE). Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634 [TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid ameliorates experimental allergic encephalomyelitis by affecting dendritic cell and monocyte development. Zhan XX; Liu Y; Yang JF; Wang GY; Mu L; Zhang TS; Xie XL; Wang JH; Liu YM; Kong QF; Li HL; Sun B Immunology; 2013 Apr; 138(4):333-45. PubMed ID: 23181351 [TBL] [Abstract][Full Text] [Related]
14. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation. Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198 [TBL] [Abstract][Full Text] [Related]
15. MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE. Mony JT; Khorooshi R; Owens T Mult Scler; 2014 Sep; 20(10):1312-21. PubMed ID: 24552747 [TBL] [Abstract][Full Text] [Related]